Benefit of pulmonary subspecialty care for children with sickle cell disease and asthma.
Publication/Presentation Date
4-1-2022
Abstract
OBJECTIVE: Asthma is a recognized comorbidity in children with sickle cell disease (SCD). It increases the risk of acute chest syndrome (ACS), vaso-occlusive episodes, and early mortality. We aim to determine whether evaluation and management of children with SCD and asthma by a pulmonologist reduce rate of asthma exacerbation and ACS.
METHODS: The study included 192 patients with SCD (0-21 years) followed at Children's Hospital of Philadelphia Hematology between January 1, 2015, and December 31, 2018, with a diagnosis of asthma, wheeze, or cough. Patients were placed in two groups: those evaluated by a pulmonologist (SCD-A-P) and those not (SCD-A). Rates of emergency department (ED) visits and hospitalizations for asthma exacerbation and ACS were compared between groups and over time.
RESULTS: SCD-A-P patients (n = 70) were predominantly SCD type SS with lower hemoglobin and hematocrit compared to SCD-A patients (n = 122). SCD-A-P started with a higher average rate of hospital visits for asthma exacerbation and ACS per year (2.69 [1.02-4.37]) compared to SCD-A (0.43 [0.24-0.63]), (p < 0.001). For SCD-A-P patients with at least one hospital visit (n = 48), the average rate decreased from 3.93 (1.57-6.29) to 0.85 (0.48-1.23) following pulmonary consultation (p = 0.014) and was comparable to the SCD-A rate by study end.
CONCLUSION: SCD-A-P was mainly SCD type SS and had higher ED/hospitalization rates for asthma exacerbation and ACS compared to SCD-A, but the rates significantly decreased following pulmonology consultation. These findings support the pulmonologist's role in the multidisciplinary care of SCD patients and highlight the need for evidence-based asthma guidelines for children with SCD.
Volume
57
Issue
4
First Page
885
Last Page
893
ISSN
1099-0496
Published In/Presented At
Saxena, S., Afolabi-Brown, O., Ballester, L., Schmucker, N., Smith-Whitley, K., Allen, J., & Bhandari, A. (2022). Benefit of pulmonary subspecialty care for children with sickle cell disease and asthma. Pediatric pulmonology, 57(4), 885–893. https://doi.org/10.1002/ppul.25845
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
35068085
Department(s)
Department of Pediatrics
Document Type
Article